Testing Archives - Insights https://news.mayocliniclabs.com/category/testing/ Get the latest news and education from Mayo Clinic Laboratories Thu, 17 Jul 2025 19:24:43 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.2 Featured new tests in quarter two of 2025 https://news.mayocliniclabs.com/2025/07/22/featured-new-tests-in-quarter-two-of-2025/ https://news.mayocliniclabs.com/2025/07/22/featured-new-tests-in-quarter-two-of-2025/#respond Tue, 22 Jul 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=117360 Featured new tests in quarter two of 2025In the second quarter of 2025, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.

The post Featured new tests in quarter two of 2025 appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/07/22/featured-new-tests-in-quarter-two-of-2025/feed/ 0 Expanded Assay Better Identifies Hereditary Pancreatitis: Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC https://news.mayocliniclabs.com/2025/07/15/expanded-assay-better-identifies-hereditary-pancreatitis-linda-hasadsri-m-d-ph-d-and-huong-cabral-m-s-cgc/ https://news.mayocliniclabs.com/2025/07/15/expanded-assay-better-identifies-hereditary-pancreatitis-linda-hasadsri-m-d-ph-d-and-huong-cabral-m-s-cgc/#respond Tue, 15 Jul 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=113685 Expanded Assay Better Identifies Hereditary Pancreatitis: Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGCLinda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC, explain how Mayo Clinic Laboratories' expanded test panel captures rarer as well as more common genetic causes of hereditary pancreatitis. That information is key to managing patients' enhanced risk for pancreatic cancer.

The post Expanded Assay Better Identifies Hereditary Pancreatitis: Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/07/15/expanded-assay-better-identifies-hereditary-pancreatitis-linda-hasadsri-m-d-ph-d-and-huong-cabral-m-s-cgc/feed/ 0 Labile Copper Test Enhances Evaluation for Wilson’s Disease: Joshua Bornhorst, Ph.D. https://news.mayocliniclabs.com/2025/07/01/labile-copper-test-enhances-evaluation-for-wilsons-disease-joshua-bornhorst-ph-d/ https://news.mayocliniclabs.com/2025/07/01/labile-copper-test-enhances-evaluation-for-wilsons-disease-joshua-bornhorst-ph-d/#respond Tue, 01 Jul 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=116134 Labile Copper Test Enhances Evaluation for Wilson’s Disease: Joshua Bornhorst, Ph.D.Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' labile copper assay (Mayo ID: LBCS) improves upon standard blood tests for Wilson's disease. The new assay measures not just overall copper but also the fraction of copper that is bioavailable, or labile bound.

The post Labile Copper Test Enhances Evaluation for Wilson’s Disease: Joshua Bornhorst, Ph.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/07/01/labile-copper-test-enhances-evaluation-for-wilsons-disease-joshua-bornhorst-ph-d/feed/ 0 Assay Aids Diagnosis of Resistant Hypertension: John Lieske, M.D., and Sandra Taler, M.D. https://news.mayocliniclabs.com/2025/06/24/assay-aids-diagnosis-of-resistant-hypertension-john-lieske-m-d-and-sandra-taler-m-d/ https://news.mayocliniclabs.com/2025/06/24/assay-aids-diagnosis-of-resistant-hypertension-john-lieske-m-d-and-sandra-taler-m-d/#respond Tue, 24 Jun 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=111254 Assay Aids Diagnosis of Resistant Hypertension: John Lieske, M.D., and Sandra Taler, M.D.John Lieske, M.D., and Sandra Taler, M.D., explain how Mayo Clinic Laboratories' mass spectrometry assay helps evaluate patients for resistant hypertension. The test can detect antihypertensive medications in urine, providing evidence of whether patients are actually absorbing their medications or whether a new approach might be needed.

The post Assay Aids Diagnosis of Resistant Hypertension: John Lieske, M.D., and Sandra Taler, M.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/06/24/assay-aids-diagnosis-of-resistant-hypertension-john-lieske-m-d-and-sandra-taler-m-d/feed/ 0 Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D. https://news.mayocliniclabs.com/2025/06/17/quantitative-adenovirus-assay-better-informs-post-transplant-care-joseph-yao-m-d/ https://news.mayocliniclabs.com/2025/06/17/quantitative-adenovirus-assay-better-informs-post-transplant-care-joseph-yao-m-d/#respond Tue, 17 Jun 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=116491 Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.Joseph Yao, M.D., explains how Mayo Clinic Laboratories' new quantitative assay (Mayo ID: ADVQU) goes beyond qualitative testing to evaluate transplant patients for adenovirus infection. Adenovirus can cause life-threatening disease in immunocompromised transplant patients, especially children.

The post Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/06/17/quantitative-adenovirus-assay-better-informs-post-transplant-care-joseph-yao-m-d/feed/ 0 Featured new tests in quarter one of 2025 https://news.mayocliniclabs.com/2025/04/23/featured-new-tests-in-quarter-one-of-2025/ https://news.mayocliniclabs.com/2025/04/23/featured-new-tests-in-quarter-one-of-2025/#respond Wed, 23 Apr 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=115827 Featured new tests in quarter one of 2025In the first quarter of 2025, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.

The post Featured new tests in quarter one of 2025 appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/04/23/featured-new-tests-in-quarter-one-of-2025/feed/ 0 Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D. https://news.mayocliniclabs.com/2025/04/15/reflex-test-guides-precise-care-for-arsenic-exposure-paul-jannetto-ph-d/ https://news.mayocliniclabs.com/2025/04/15/reflex-test-guides-precise-care-for-arsenic-exposure-paul-jannetto-ph-d/#respond Tue, 15 Apr 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=115593 Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D.Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' SPAS test identifies the form of arsenic present in patients with arsenic exposure. That information is important for determining the potential level of harm and for removing the patient from the arsenic source to ease symptoms and prevent cancer risk.

The post Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/04/15/reflex-test-guides-precise-care-for-arsenic-exposure-paul-jannetto-ph-d/feed/ 0 Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACP https://news.mayocliniclabs.com/2025/04/08/comprehensive-genetic-test-guides-prescribing-of-a-transplant-anti-rejection-drug-jessica-wright-pharm-d-bcacp-r-ph/ https://news.mayocliniclabs.com/2025/04/08/comprehensive-genetic-test-guides-prescribing-of-a-transplant-anti-rejection-drug-jessica-wright-pharm-d-bcacp-r-ph/#respond Tue, 08 Apr 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=115418 Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACPJessica Wright, Pharm.D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after non-liver organ transplants. Optimal tacrolimus levels are one of the important factors in survival of the transplanted organ.

The post Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACP appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/04/08/comprehensive-genetic-test-guides-prescribing-of-a-transplant-anti-rejection-drug-jessica-wright-pharm-d-bcacp-r-ph/feed/ 0 Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D. https://news.mayocliniclabs.com/2025/01/21/assay-identifies-most-known-membranous-nephropathy-antigens-sanjeev-sethi-m-d-ph-d/ https://news.mayocliniclabs.com/2025/01/21/assay-identifies-most-known-membranous-nephropathy-antigens-sanjeev-sethi-m-d-ph-d/#respond Tue, 21 Jan 2025 14:00:00 +0000 https://news.mayocliniclabs.com/?p=113161 Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D.Sanjeev Sethi, M.D., Ph.D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal management of this serious kidney disease.

The post Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/01/21/assay-identifies-most-known-membranous-nephropathy-antigens-sanjeev-sethi-m-d-ph-d/feed/ 0 CPT codes and LOINC update: December 2024 https://news.mayocliniclabs.com/2025/01/02/cpt-codes-and-loinc-update-december-2024/ https://news.mayocliniclabs.com/2025/01/02/cpt-codes-and-loinc-update-december-2024/#respond Thu, 02 Jan 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=114041 CPT codes and LOINC update: December 2024This will be the last CPT Codes and LOINC update. Read why.

The post CPT codes and LOINC update: December 2024 appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/01/02/cpt-codes-and-loinc-update-december-2024/feed/ 0